$MYOV $PFE 📰 Myovant Sciences and Pfizer Announce First Participant Dosed in Phase 3 SERENE Study Evaluating Contraceptive Efficacy of Once-Daily Relugolix Combination Tablet

https://quantisnow.com/insight/606413?s=s

#majorpharmaceuticals #healthcare

RT@TaniaBradkin:@DanPriceSeattle Abolish all #healthcare worker #StudentDebt

"Health is Wealth"

Either for yourself or for the Medical Firms!

#SundayThoughts
#healthcare
#HealthIsWealth

What You Should Know About Delta Dental Health Insurance? https://t.co/AKfhp88YjV #healthinsurance #obamacare #Medicare #healthcare

Wow #healthcare #kindness and #Innovation https://t.co/k9cioklnxE

#digitalidentity for #healthcare is a hot topic, with@Mastercard and@icanbwell partnering on patient ID, a region… https://t.co/n5KXTHqf5J

$AVXL 📜 SEC Form S-8 filed by Anavex Life Sciences Corp.

https://quantisnow.com/insight/605155?s=s

#healthcare

$ATNF 📜 SEC Form 4: Marc Feldmann was granted 20,910 units of Common Stock, increasing direct ownership by 0.81% to 2,617,758 units

https://quantisnow.com/insight/604824?s=s

#majorpharmaceuticals #healthcare

$ATNF 📜 SEC Form 4: B. Jonathan Rothbard was granted 24,307 units of Common Stock, increasing direct ownership by 5% to 560,449 units

https://quantisnow.com/insight/604815?s=s

#majorpharmaceuticals #healthcare

#SP500 $SPX HeatMap 2 week Performance #large #healthcare
stocks: $JNJ $UNH $ABT $PFE

https://www.finscreener.org/map/map/nq100

$AFMD 📜 SEC Form 6-K filed by Affimed N.V.

https://quantisnow.com/insight/603085?s=s

#majorpharmaceuticals #healthcare

$AFMD 📰 Affimed Announces Presentation at AACR Highlighting Initial Data from Phase 1 Study of Cord Blood-derived Natural Killer Cells Pre-complexed with Innate Cell Engager AFM13

https://quantisnow.com/insight/602926?s=s

#majorpharmaceuticals #healthcare

$ATNF 📜 SEC Form 4: Lawrence Steinman was granted 22,585 units of Common Stock, increasing direct ownership by 4% to 592,358 units

https://quantisnow.com/insight/599421?s=s

#majorpharmaceuticals #healthcare

$BIIB 📃 Biogen and Bio-Thera Solutions Announce Commercialization and License Agreement for Proposed Biosimilar Currently in Phase 3 With the Potential to Treat Moderate to Severe Rheumatoid Arthritis Biogen Inc.

https://quantisnow.com/insight/599088?s=s

#healthcare

$AFMD 📃 Affimed to Report Full Year 2020 Financial Results &; Corporate Update on April 15, 2021

https://quantisnow.com/insight/598923?s=s

#majorpharmaceuticals #healthcare